Most studies of cancer stem cells (CSC) involve the inoculation of cells from human tumors
into immunosuppressed mice, preventing an assessment on the immunologic interactions …

The inability to target cancer stem cells (CSC) may be a significant factor contributing to
treatment failure. We have developed a strategy to target the CSC populations in melanoma …

It is becoming increasingly clear that virtually all types of human cancers harbor a small
population of stem-like cancer cells (ie, cancer stem cells, CSCs). These CSCs preexist in …

Cancer stem cells (CSCs) represent a small subset of tumor cells which have the ability to
self-renew and generate the diverse cells that comprise the tumor bulk. They are …

Despite recent advances in diagnosis and therapy having improved cancer outcome, many
patients still do not respond to treatments, resulting in the progression or relapse of the …

Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor, with current
treatment remaining palliative. Immunotherapies harness the body's own immune system to …

Cancer stem‐like cells (CSC)/cancer‐initiating cells (CIC) are defined as minor
subpopulations of cancer cells that are endowed with properties of higher tumor‐initiating …

Cancer stem cells (CSCs) are one of the reasons for the relapse of cancer cells and
metastasis. They have drug resistance against most chemotherapeutic agents. CSCs are …

Tumor lesions comprise multiple subpopulations of cells including those endowed with
“stemness” properties. The latter cells are responsible of tumor initiation, metastasis …

Cancer stem cells (CSCs) are demonstrated to be usually less sensitive to conventional
methods of cancer therapies, resulting in tumor relapse. It is well-known that an ideal …